A normalization strategy for extreme proteome regulation reveals distinct targets of eIF4A1/2 and their inhibitor silvestrol
In the authors' words
Cells rapidly adjust protein synthesis in response to stress, signalling and drugs, often converging on the cell's translation machinery affecting the synthesis of multiple proteins simultaneously. Nascent proteome analysis, combining pulsed SILAC labelling with enrichment of newly synthesized proteins (NSPs), can measure these changes proteome-wide. However, quantitative proteomics relies on normalization methods that assume most proteins remain unchanged. When protein synthesis shifts globally, this assumption fails: normalization then erases the biological effect, whereas omitting it leads to misinterpretation of data. Since no approach has so far reliably preserved global changes in protein synthesis, we developed labelled protein ratio (LPR) normalization, which uses the ratio of newly synthesized to pre-existing protein in the global proteome as an internal scaling factor. Two SILAC benchmarks showed that this factor is accurate down to a few percent of labelled protein and recovers defined global differences, whereas twelve established normalization methods did not. Applied to cycloheximide treatment, LPR normalization revealed a 57% decrease in synthesis, which median normalization reported as balanced up- and down-regulation with spurious increases in multiple proteins. After depletion of the core translation initiation factor eIF4A1, LPR normalization uncovered a broad translational repression that median normalization largely masked, while eIF4A inhibition with silvestrol showed a divergent pattern, suggesting secondary effects. LPR normalization thus provides a general strategy for quantifying global changes in protein synthesis.
Appeared: Thursday, November 19. bioRxiv. Preprint, not yet peer-reviewed.